Combination therapeutic strategy to fight against triple-negative breast cancer

被引：0
|
作者：
Svajda, Laura
Randelovic, Ivan
Surguta, Sara Eszter
Baranyi, Marcell
Kenessey, Istvan
Cserepes, Mihaly
Tovari, Jozsef
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4131
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy
    Hiroshi Yagata
    Yuka Kajiura
    Hideko Yamauchi
    Breast Cancer, 2011, 18 : 165 - 173
  • [22] Ferroptosis Heterogeneity in Triple-Negative Breast Cancer Reveals an Innovative Immunotherapy Combination Strategy
    Yang, Fan
    Xiao, Yi
    Ding, Jia-Han
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    CANCER RESEARCH, 2023, 83 (05)
  • [23] Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
    Yang, Fan
    Xiao, Yi
    Ding, Jia-Han
    Jin, Xi
    Ma, Ding
    Li, Da-Qian
    Shi, Jin-Xiu
    Huang, Wei
    Wang, Yi-Pin
    Jiang, Yi-Zhou
    Shao, Zhi-Ming
    CELL METABOLISM, 2022, 35 (01) : 84 - 100
  • [24] Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy
    Dheeraj, Arpit
    Marques, Fernando Jose Garcia
    Tailor, Dhanir
    Bermudez, Abel
    Resendez, Angel
    Pandrala, Mallesh
    Grau, Benedikt
    Kumar, Praveen
    Haley, Carrsyn B.
    Honkala, Alexander
    Kujur, Praveen
    Jeffrey, Stefanie S.
    Pitteri, Sharon
    V. Malhotra, Sanjay
    CELL REPORTS MEDICINE, 2024, 5 (05)
  • [25] Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer
    Liu, Siyan
    Li, Jing
    Gu, Lin
    Wu, Kunzhe
    Xing, Hua
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 17 : 5209 - 5227
  • [26] Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer
    Barkat, Md Abul
    Harshita
    Ahmad, Javed
    Khan, Mohammad Ahmed
    Beg, Sarwar
    Ahmad, Farhan Jalees
    CURRENT DRUG TARGETS, 2018, 19 (01) : 70 - 80
  • [27] Innovative therapeutic strategy against triple-negative breast cancer based on the p300-targeting curcumin analogues
    Masuda, Tatsuya
    Watanabe, Takayoshi
    Rohmad, Yudi U.
    Ozaki, Toshinori
    Nakamura, Rikiya
    Edy, Meiyanto
    Kamikubo, Yasuhiko
    CANCER SCIENCE, 2025, 116 : 188 - 188
  • [28] Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer
    Sai, Boya Manasa
    Dinakar, Yirivinti Hayagreeva
    Kumar, Hitesh
    Jain, Rupshee
    Kesharwani, Sharyu
    Kesharwani, Siddharth S.
    Mudavath, Shyam lal
    Ramkishan, Ajmeer
    Jain, Vikas
    THERAPEUTIC DELIVERY, 2024, 15 (11) : 871 - 891
  • [29] Developing combination therapies with biologics in triple-negative breast cancer
    Gaudio, Gilda
    Martino, Enzo
    Pellizzari, Gloria
    Cavallone, Matteo
    Castellano, Grazia
    Omar, Abeid
    Katselashvili, Lika
    Trapani, Dario
    Curigliano, Giuseppe
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (10) : 1075 - 1094
  • [30] Development of novel combination therapy for triple-negative breast cancer
    Lee, H.
    Lee, K.
    Lee, J.
    Yoon, K.
    Mohammad, A. M.
    Park, H. S.
    Park, J. S.
    Lee, S. -T.
    Sohn, J.
    BREAST, 2019, 44 : S36 - S37
12345